ATE74929T1 - Derivate von dextran mit antikoagulierenden und antikomplementaeren eigenschaften, ihre herstellung und ihre biologischen anwendungen. - Google Patents

Derivate von dextran mit antikoagulierenden und antikomplementaeren eigenschaften, ihre herstellung und ihre biologischen anwendungen.

Info

Publication number
ATE74929T1
ATE74929T1 AT84402466T AT84402466T ATE74929T1 AT E74929 T1 ATE74929 T1 AT E74929T1 AT 84402466 T AT84402466 T AT 84402466T AT 84402466 T AT84402466 T AT 84402466T AT E74929 T1 ATE74929 T1 AT E74929T1
Authority
AT
Austria
Prior art keywords
anticoagulatory
anticomplementary
properties
production
biological applications
Prior art date
Application number
AT84402466T
Other languages
English (en)
Inventor
Monique Mauzac
Jacqueline Jozefonvicz
Marcel Jozefonvicz
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay Sa filed Critical Choay Sa
Application granted granted Critical
Publication of ATE74929T1 publication Critical patent/ATE74929T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT84402466T 1983-11-30 1984-11-30 Derivate von dextran mit antikoagulierenden und antikomplementaeren eigenschaften, ihre herstellung und ihre biologischen anwendungen. ATE74929T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8319110A FR2555589B1 (fr) 1983-11-30 1983-11-30 Nouveaux derives du dextrane a activites anticoagulante en anti-inflammatoire, leur procede de preparation et utilisation de ces derives en tant qu'anticoagulants et en tant que substituts du plasma sanguin
EP84402466A EP0146455B1 (de) 1983-11-30 1984-11-30 Derivate von Dextran mit antikoagulierenden und antikomplementären Eigenschaften, ihre Herstellung und ihre biologischen Anwendungen

Publications (1)

Publication Number Publication Date
ATE74929T1 true ATE74929T1 (de) 1992-05-15

Family

ID=9294687

Family Applications (2)

Application Number Title Priority Date Filing Date
AT90122614T ATE110391T1 (de) 1983-11-30 1984-11-30 Derivate von dextran mit antikoagulierenden und antikomplementären eigenschaften, ihre herstellung und ihre biologischen anwendungen.
AT84402466T ATE74929T1 (de) 1983-11-30 1984-11-30 Derivate von dextran mit antikoagulierenden und antikomplementaeren eigenschaften, ihre herstellung und ihre biologischen anwendungen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT90122614T ATE110391T1 (de) 1983-11-30 1984-11-30 Derivate von dextran mit antikoagulierenden und antikomplementären eigenschaften, ihre herstellung und ihre biologischen anwendungen.

Country Status (7)

Country Link
US (1) US4740594A (de)
EP (2) EP0146455B1 (de)
JP (1) JPH0625202B2 (de)
AT (2) ATE110391T1 (de)
CA (1) CA1231334A (de)
DE (2) DE3486341T2 (de)
FR (1) FR2555589B1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE453394B (sv) * 1986-07-07 1988-02-01 Pharmacia Ab Forfarande for framstellning av sulfaterade polysackarider genom anvendning av ett reducerande medel for sulfateringsreaktionen
FR2635327B1 (fr) * 1988-08-10 1990-11-16 Guerbet Sa Polymeres iodes, a squelette dextrane, leurs procedes de preparation et leurs applications comme produits de contraste
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
US5693625A (en) * 1989-03-09 1997-12-02 Therapeutiques Substitutives Method of regenerating cells and tissues using functionalized dextrans
FR2651436B1 (fr) * 1989-09-05 1994-09-09 Sanofi Sa Compositions pharmaceutiques contenant un derive substitue soluble de dextrane.
FR2657782B1 (fr) * 1990-02-06 1992-05-22 Therapeutiques Substitutives Nouvel agent antitumoral derive du dextrane.
US5114932A (en) * 1990-11-30 1992-05-19 Runge Thomas M Hyperosmolar oxyreplete hemosubstitute
US5306711A (en) * 1992-06-24 1994-04-26 Georgetown University Organ preservative solution
US6458762B1 (en) 1994-03-28 2002-10-01 Baxter International, Inc. Therapeutic use of hemoglobin for preserving tissue viability and reducing restenosis
FR2718026B1 (fr) * 1994-03-30 1997-01-17 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement des muscles.
FR2772382B1 (fr) * 1997-12-11 2000-03-03 Solutions Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
AU3631999A (en) * 1998-12-04 2000-06-26 Iliya Yakovlevich Ashkinazi Biologically active carboxymethyldextran n-arylamides
US6060461A (en) * 1999-02-08 2000-05-09 Drake; James Franklin Topically applied clotting material
FR2794976B1 (fr) * 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
US6492103B1 (en) 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
FR2807326B1 (fr) * 2000-04-10 2002-08-23 Therapeutiques Substitutives Prothese vasculaire impregnee de dextrane reticule et/ou d'un derive fonctionnalise de dextane reticule et son procede de preparation
EP1403379A1 (de) * 2002-09-24 2004-03-31 QIAGEN GmbH Verbesserte Koamplifikation von Nukleinsäuren
FR2861308A1 (fr) 2003-10-28 2005-04-29 Organes Tissus Regeneration Re Utilisation de polymeres biocompatibles pour la preparation d'une composition pharmaceutique, dermatologique ou cosmetique destinee a la prevention, au soulagement ou au traitement des genes, desagrements et douleurs
CA2543530C (fr) 2003-10-28 2014-02-04 Denis Barritault Utilisation de polymeres biocompatibles pour la preparation d'une composition ou d'un dispositif medical
FR2914305B1 (fr) * 2007-03-29 2009-07-03 Proteins & Peptides Man Dextran fonctionnalise par des amino-acides hydrophobes.
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
FR2966248B1 (fr) * 2010-10-18 2020-05-01 Centre National De La Recherche Scientifique (Cnrs) Procede de fonctionnalisation de surfaces pour la detection d'analytes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2216617A (en) * 1938-08-31 1940-10-01 Katz Jacob Surface active anionic compounds of amino alcohols
US2989518A (en) * 1957-05-13 1961-06-20 Ohio Commw Eng Co Carboxymethyl benzyl dextran
FR2484419B1 (fr) * 1980-06-16 1985-10-04 Meito Sangyo Kk Derives du dextranne et leurs sels, leur preparation et produits cosmetiques comprenant ces substances
SE8103137L (sv) * 1981-05-19 1982-11-20 Pharmacia Ab Polymer med kvartera aminogrupper

Also Published As

Publication number Publication date
EP0146455A2 (de) 1985-06-26
FR2555589B1 (fr) 1986-05-16
US4740594A (en) 1988-04-26
FR2555589A1 (fr) 1985-05-31
CA1231334A (fr) 1988-01-12
DE3485658D1 (de) 1992-05-21
EP0428182B1 (de) 1994-08-24
JPH0625202B2 (ja) 1994-04-06
EP0428182A1 (de) 1991-05-22
DE3486341T2 (de) 1995-05-04
JPS60135401A (ja) 1985-07-18
ATE110391T1 (de) 1994-09-15
EP0146455B1 (de) 1992-04-15
EP0146455A3 (en) 1986-03-26
DE3486341D1 (de) 1994-09-29

Similar Documents

Publication Publication Date Title
ATE74929T1 (de) Derivate von dextran mit antikoagulierenden und antikomplementaeren eigenschaften, ihre herstellung und ihre biologischen anwendungen.
FI98065B (fi) Menetelmiä valmistaa substituoituja 1,3-oksatiolaaneja, joilla on virustenvastaisia ominaisuuksia
DE69021263D1 (de) Fibronektinbindungsprotein und dessen Herstellung.
DE69008326D1 (de) Mehrstufenverfahren zur Herstellung von Hexafluoropropylen.
DE69003000D1 (de) Verfahren zur kontinuierlichen Herstellung von Polyethylenmaterial mit erhöhter Stärke und hohem Elastizitätsmodul.
DE59008005D1 (de) Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden.
DE3584571D1 (de) Hydrokrackkatalysatoren und -verfahren mit nichtzeolitischen molekularsieben.
DE69010171D1 (de) Mehrstufenverfahren zur Herstellung von Hexafluoropropylen.
DE68905232D1 (de) Verfahren zur herstellung von thioether-funktion enthaltendem polybuten.
DE3683883D1 (de) Verfahren zur herstellung von organopolysilanen und verwendung der so hergestellten organopolysilane.
DE3853446D1 (de) Fibronectinbindungsprotein und dessen Herstellung.
ATE138925T1 (de) Erythromycinderivate, herstellung und verwendung davon
DE59206398D1 (de) Verfahren zur Herstellung von 1-Carbamoyl-pyrazolen
ATE83477T1 (de) Phenylharnstoffe.
DE59003230D1 (de) Verfahren zur Herstellung von 2,4- bzw. 2,6-Dihalogen-anilin.
ATE74353T1 (de) Verfahren zur herstellung von n,n(dibenzohexatrienylen)harnstoffen.
ATE18035T1 (de) Zusammensetzungen von ferrosilikatmolekularsieben.
ATE99687T1 (de) Strobilurinderivate, ihre herstellung und verwendung.
DE59103673D1 (de) Spezielle Dihydroxydiphenylbicycloalkane, ihre Herstellung und ihre Verwendung zur Herstellung von hochmolekularen Polycarbonaten.
SU606843A1 (ru) Изделие, выполненное из кварцевой керамики
ATE74115T1 (de) Verfahren zur herstellung von glasur-agglomeraten durch extrusion, nach diesem verfahren erzeugte glasuren und damit glasierte werkstuecke.
DE3854758D1 (de) Verfahren zur Herstellung von Poly(para-phenylen-sulfid).
DE69007941D1 (de) Mesophasepech zur Herstellung von Carbonmaterialien.
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
ATE28209T1 (de) Stabilisierung von poly(arylensulfiden).

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time